v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 18,681 $ 15,333
Adjustments to reconcile net income to net cash provided by operations:    
Depreciation and amortization 11,974 14,835
Stock-based compensation expense 2,596 3,122
Provision for deferred income taxes 6,164 (2,196)
Credit loss expense 19 1,040
Gain on sale of assets (1,557) (1,049)
Gain on insurance recovery 0 (874)
Amortization of original issue discount and debt issuance costs 313 260
Change in assets and liabilities:    
(Increase) decrease in receivables (6,283) 4,369
Decrease in inventories 3,596 12,158
Increase in other assets (1,924) (1,524)
Increase in accounts payable 1,823 647
Decrease in accrued liabilities and other (5,134) (6,590)
Net cash provided by operating activities 30,268 39,531
Cash flows from investing activities:    
Capital expenditures (21,705) (20,468)
Proceeds from divestitures 14,485 0
Proceeds from sale of property, plant and equipment 3,320 2,042
Proceeds from insurance property claim 0 1,385
Other investing activities 3,089 0
Net cash provided by (used in) investing activities (811) (17,041)
Cash flows from financing activities:    
Borrowings on lines of credit 0 87,444
Payments on lines of credit 0 (101,077)
Debt issuance costs (797) 0
Purchases of treasury stock (19,291) (4,332)
Proceeds from employee stock plans 0 17
Other financing activities (1,704) (7,040)
Net cash used in financing activities (21,792) (24,988)
Effect of exchange rate changes on cash 110 (961)
Net increase (decrease) in cash, cash equivalents, and restricted cash 7,775 (3,459)
Cash, cash equivalents, and restricted cash at beginning of period 18,237 38,901
Cash, cash equivalents, and restricted cash at end of period $ 26,012 $ 35,442